COVID-19 PHASE II RANDOMIZED STUDY OF CONVALESCENT PLASMA FROM RECOVERED COVID-19 DONORS COLLECTED BY PLASMAPHERESIS AS TREATMENT FOR SUBJECTS WITH EARLY COVID-19 INFECTION
$1,093,693FY2021Department of the ArmyDOD
Hmh Hospitals Corporation
Hmh Hospitals Corporation